186 related articles for article (PubMed ID: 32240619)
1. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4
Krishnan A; Katsumi T; Guicciardi ME; Azad AI; Ozturk NB; Trussoni CE; Gores GJ
Am J Pathol; 2020 Jun; 190(6):1284-1297. PubMed ID: 32240619
[TBL] [Abstract][Full Text] [Related]
2. Targeted Apoptosis of Ductular Reactive Cells Reduces Hepatic Fibrosis in a Mouse Model of Cholestasis.
Azad AI; Krishnan A; Troop L; Li Y; Katsumi T; Pavelko K; Kostallari E; Guicciardi ME; Gores GJ
Hepatology; 2020 Sep; 72(3):1013-1028. PubMed ID: 32128842
[TBL] [Abstract][Full Text] [Related]
3. Knockout of the Tachykinin Receptor 1 in the Mdr2
Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
[TBL] [Abstract][Full Text] [Related]
7. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
9. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.
Stiedl P; McMahon R; Blaas L; Stanek V; Svinka J; Grabner B; Zollner G; Kessler SM; Claudel T; Müller M; Mikulits W; Bilban M; Esterbauer H; Eferl R; Haybaeck J; Trauner M; Casanova E
Hepatology; 2015 Feb; 61(2):613-26. PubMed ID: 25179284
[TBL] [Abstract][Full Text] [Related]
11. Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
Yu D; Cai SY; Mennone A; Vig P; Boyer JL
Liver Int; 2018 Jun; 38(6):1128-1138. PubMed ID: 29356312
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.
Svinka J; Pflügler S; Mair M; Marschall HU; Hengstler JG; Stiedl P; Poli V; Casanova E; Timelthaler G; Sibilia M; Eferl R
J Mol Med (Berl); 2017 Jan; 95(1):109-117. PubMed ID: 27568040
[TBL] [Abstract][Full Text] [Related]
13. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
[TBL] [Abstract][Full Text] [Related]
14. Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.
Baghdasaryan A; Fickert P; Fuchsbichler A; Silbert D; Gumhold J; Hörl G; Langner C; Moustafa T; Halilbasic E; Claudel T; Trauner M
Liver Int; 2008 Aug; 28(7):948-58. PubMed ID: 18410282
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury.
Krishnan A; Ozturk NB; Cutshaw KA; Guicciardi ME; Kitagataya T; Olson KE; Pavelko KD; Sherman W; Wixom AQ; Jalan-Sakrikar N; Baez-Faria M; Gutierrez F; Gores GJ
Sci Rep; 2024 Jan; 14(1):2145. PubMed ID: 38273071
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin reverses ductular reaction and hepatic fibrosis in a rodent model of cholestasis.
Petrescu AD; Grant S; Williams E; Frampton G; Reinhart EH; Nguyen A; An S; McMillin M; DeMorrow S
Sci Rep; 2020 Sep; 10(1):16024. PubMed ID: 32994489
[TBL] [Abstract][Full Text] [Related]
17. TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.
Idrissova L; Malhi H; Werneburg NW; LeBrasseur NK; Bronk SF; Fingas C; Tchkonia T; Pirtskhalava T; White TA; Stout MB; Hirsova P; Krishnan A; Liedtke C; Trautwein C; Finnberg N; El-Deiry WS; Kirkland JL; Gores GJ
J Hepatol; 2015 May; 62(5):1156-63. PubMed ID: 25445398
[TBL] [Abstract][Full Text] [Related]
18. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
[TBL] [Abstract][Full Text] [Related]
19. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
[TBL] [Abstract][Full Text] [Related]
20. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
